Thyrocare Technologies Ltd
NSE:THYROCARE

Watchlist Manager
Thyrocare Technologies Ltd Logo
Thyrocare Technologies Ltd
NSE:THYROCARE
Watchlist
Price: 450.6 INR 2.35%
Market Cap: ₹71.7B

Operating Margin

22.9%
Current
Improving
by 5.5%
vs 3-y average of 17.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
22.9%
=
Operating Income
₹1.7B
/
Revenue
₹7.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
22.9%
=
Operating Income
₹1.7B
/
Revenue
₹7.6B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Thyrocare Technologies Ltd
NSE:THYROCARE
70B INR
Loading...
US
CVS Health Corp
NYSE:CVS
105.6B USD
Loading...
US
Cigna Group
XMUN:CGN
63B EUR
Loading...
US
Cigna Corp
NYSE:CI
74.7B USD
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
27B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.7B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.1B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.2B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.5B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.1B AUD
Loading...

Market Distribution

Higher than 85% of companies in India
Percentile
85th
Based on 5 437 companies
85th percentile
22.9%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Thyrocare Technologies Ltd
Glance View

Market Cap
71.7B INR
Industry
Health Care

Thyrocare Technologies Ltd. engages in provison of indepedent diagnostic and pathological laboratory services. The company is headquartered in Navi Mumbai, Maharashtra and currently employs 2,115 full-time employees. The company went IPO on 2016-05-09. The firm operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The firm offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The firm offers various kinds of tests, such as Aarogyam X, Aarogyam XL, Aarogyam 1.1, Aarogyam 1.2 and Covid Antibody GT. The company also offers Thyroxine (T4), Triiodothyronine (T3), Thyroid-stimulating hormone and Complete Vitamin Profile tests.

THYROCARE Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
22.9%
=
Operating Income
₹1.7B
/
Revenue
₹7.6B
What is Thyrocare Technologies Ltd's current Operating Margin?

The current Operating Margin for Thyrocare Technologies Ltd is 22.9%, which is above its 3-year median of 17.4%.

How has Operating Margin changed over time?

Over the last 3 years, Thyrocare Technologies Ltd’s Operating Margin has increased from 20.7% to 22.9%. During this period, it reached a low of 14.7% on Jun 30, 2023 and a high of 22.9% on Sep 30, 2025.

Back to Top